Report Detail
Global (United States, European Union and China) Novel Oral AntiCoagulants (NOAC) Market Research Report 2019-2025
- RnM3356145 |
- 25 April, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Novel Oral AntiCoagulants (NOAC) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Novel Oral AntiCoagulants (NOAC).
This report studies the global market size of Novel Oral AntiCoagulants (NOAC), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Novel Oral AntiCoagulants (NOAC) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere
Market Segment by Product Type
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Market Segment by Application
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Novel Oral AntiCoagulants (NOAC) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Novel Oral AntiCoagulants (NOAC) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Novel Oral AntiCoagulants (NOAC) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Novel Oral AntiCoagulants (NOAC) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Direct Thrombin Inhibitors
- 1.3.3 Direct Factor Xa Inhibitors
- 1.4 Market Segment by Application
- 1.4.1 Global Novel Oral AntiCoagulants (NOAC) Market Share by Application (2019-2025)
- 1.4.2 Deep Vein Thrombosis (DVT)
- 1.4.3 Pulmonary Embolism
- 1.4.4 Acute Coronary Syndrome
- 1.4.5 Hemodialysis
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Novel Oral AntiCoagulants (NOAC) Market Size
- 2.1.1 Global Novel Oral AntiCoagulants (NOAC) Revenue 2014-2025
- 2.1.2 Global Novel Oral AntiCoagulants (NOAC) Sales 2014-2025
- 2.2 Novel Oral AntiCoagulants (NOAC) Growth Rate by Regions
- 2.2.1 Global Novel Oral AntiCoagulants (NOAC) Sales by Regions 2014-2019
- 2.2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Novel Oral AntiCoagulants (NOAC) Sales by Manufacturers
- 3.1.1 Novel Oral AntiCoagulants (NOAC) Sales by Manufacturers 2014-2019
- 3.1.2 Novel Oral AntiCoagulants (NOAC) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturers (2014-2019)
- 3.2.2 Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Novel Oral AntiCoagulants (NOAC) Market Concentration Ratio (CR5 and HHI)
- 3.3 Novel Oral AntiCoagulants (NOAC) Price by Manufacturers
- 3.4 Key Manufacturers Novel Oral AntiCoagulants (NOAC) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Novel Oral AntiCoagulants (NOAC) Market
- 3.6 Key Manufacturers Novel Oral AntiCoagulants (NOAC) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Direct Thrombin Inhibitors Sales and Revenue (2014-2019)
- 4.1.2 Direct Factor Xa Inhibitors Sales and Revenue (2014-2019)
- 4.2 Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type
- 4.3 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Type
- 4.4 Novel Oral AntiCoagulants (NOAC) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Novel Oral AntiCoagulants (NOAC) Sales by Application
6 United States
- 6.1 United States Novel Oral AntiCoagulants (NOAC) Breakdown Data by Company
- 6.2 United States Novel Oral AntiCoagulants (NOAC) Breakdown Data by Type
- 6.3 United States Novel Oral AntiCoagulants (NOAC) Breakdown Data by Application
7 European Union
- 7.1 European Union Novel Oral AntiCoagulants (NOAC) Breakdown Data by Company
- 7.2 European Union Novel Oral AntiCoagulants (NOAC) Breakdown Data by Type
- 7.3 European Union Novel Oral AntiCoagulants (NOAC) Breakdown Data by Application
8 China
- 8.1 China Novel Oral AntiCoagulants (NOAC) Breakdown Data by Company
- 8.2 China Novel Oral AntiCoagulants (NOAC) Breakdown Data by Type
- 8.3 China Novel Oral AntiCoagulants (NOAC) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Novel Oral AntiCoagulants (NOAC) Breakdown Data by Company
- 9.2 Rest of World Novel Oral AntiCoagulants (NOAC) Breakdown Data by Type
- 9.3 Rest of World Novel Oral AntiCoagulants (NOAC) Breakdown Data by Application
- 9.4 Rest of World Novel Oral AntiCoagulants (NOAC) Breakdown Data by Countries
- 9.4.1 Rest of World Novel Oral AntiCoagulants (NOAC) Sales by Countries
- 9.4.2 Rest of World Novel Oral AntiCoagulants (NOAC) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Johnson & Johnson
- 10.1.1 Johnson & Johnson Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.1.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.1.5 Johnson & Johnson Recent Development
- 10.2 Bristol-Myers Squibb
- 10.2.1 Bristol-Myers Squibb Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.2.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.2.5 Bristol-Myers Squibb Recent Development
- 10.3 Boehringer Ingelheim
- 10.3.1 Boehringer Ingelheim Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.3.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.3.5 Boehringer Ingelheim Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.4.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 Daiichi Sankyo
- 10.5.1 Daiichi Sankyo Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.5.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.5.5 Daiichi Sankyo Recent Development
- 10.6 Armatheon
- 10.6.1 Armatheon Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.6.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.6.5 Armatheon Recent Development
- 10.7 Aspen
- 10.7.1 Aspen Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.7.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.7.5 Aspen Recent Development
- 10.8 AstraZeneca
- 10.8.1 AstraZeneca Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.8.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.8.5 AstraZeneca Recent Development
- 10.9 Bayer
- 10.9.1 Bayer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.9.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.9.5 Bayer Recent Development
- 10.10 Cellceutix
- 10.10.1 Cellceutix Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Novel Oral AntiCoagulants (NOAC)
- 10.10.4 Novel Oral AntiCoagulants (NOAC) Product Introduction
- 10.10.5 Cellceutix Recent Development
- 10.11 Cosmo Pharmaceuticals
- 10.12 CSL Behring
- 10.13 Eisai
- 10.14 GSK
- 10.15 Marathon Pharmaceuticals
- 10.16 Ockham Biotech
- 10.17 Perosphere
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Novel Oral AntiCoagulants (NOAC) Sales Channels
- 11.2.2 Novel Oral AntiCoagulants (NOAC) Distributors
- 11.3 Novel Oral AntiCoagulants (NOAC) Customers
12 Market Forecast
- 12.1 Global Novel Oral AntiCoagulants (NOAC) Sales and Revenue Forecast 2019-2025
- 12.2 Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Type
- 12.3 Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Application
- 12.4 Novel Oral AntiCoagulants (NOAC) Forecast by Regions
- 12.4.1 Global Novel Oral AntiCoagulants (NOAC) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Novel Oral AntiCoagulants (NOAC) . Industry analysis & Market Report on Novel Oral AntiCoagulants (NOAC) is a syndicated market report, published as Global (United States, European Union and China) Novel Oral AntiCoagulants (NOAC) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Novel Oral AntiCoagulants (NOAC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
